Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

2.6K
2.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

3.8K
3.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of hyperuricemia with valvular heart disease and the modifying effect of obesity.

The Korean journal of internal medicine·2026
Same author

Development of Virtual Reality Health Literacy: Delphi Expert Consensus Study.

Journal of medical Internet research·2026
Same author

Quantifying the Independent and Combined Contributions of Clinical, Genetic, Proteomic, and Metabolomic Signals to ASCVD Prediction.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

Cellular immunology data enable clinical severity prediction via supervised machine learning.

iScience·2026
Same author

Genetic proxies of GLP1R expression are associated with lower risk of psoriasis and psoriatic arthritis.

The British journal of dermatology·2026
Same author

Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: Apr 24, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.3K

Knowledge-driven genomic interactions: an application in ovarian cancer.

Dokyoon Kim1, Ruowang Li1, Scott M Dudek1

  • 1Department of Biochemistry and Molecular Biology, Center for Systems Genomics, Pennsylvania State University, University Park, Pennsylvania, USA.

Biodata Mining
|September 13, 2014
PubMed
Summary

This study introduces a new method using knowledge-driven genomic interactions to predict cancer outcomes, improving accuracy and interpretability for ovarian cancer. The approach integrates diverse biological knowledge for better diagnostic and therapeutic insights.

Keywords:
Clinical outcome predictionGrammatical evolution neural networkIntegrative analysisKnowledge-driven genomic interactionOvarian cancer

More Related Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Related Experiment Videos

Last Updated: Apr 24, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.3K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K

Area of Science:

  • Genomics and Bioinformatics
  • Cancer Research
  • Computational Biology

Background:

  • Clinical outcome prediction in cancer is crucial for understanding tumorigenesis and developing therapies.
  • Gene expression profiles show promise but vary across datasets and lack context of gene interactions.
  • Predicting cancer outcomes requires understanding complex gene networks and pathway cooperation, incorporating expert knowledge.

Purpose of the Study:

  • To develop a novel approach for identifying knowledge-driven genomic interactions for cancer clinical outcome prediction.
  • To apply grammatical evolution neural networks (GENN) for discovering models associated with cancer clinical phenotypes.
  • To demonstrate the utility of this approach using ovarian cancer data for clinical stage prediction.

Main Methods:

  • Proposed a novel approach for knowledge-driven genomic interaction identification using GENN.
  • Integrated diverse biological knowledge sources, including pathway-pathway and pathway-protein family interactions.
  • Utilized ovarian cancer data from The Cancer Genome Atlas (TCGA) for a pilot study on clinical stage prediction.

Main Results:

  • Identified knowledge-driven genomic interactions associated with cancer stage by integrating different biological knowledge bases.
  • Achieved 78.82% balanced accuracy with an integrated model, outperforming models using single data types.
  • Generated more interpretable models framed within specific biological pathways and expert knowledge.

Conclusions:

  • The developed approach successfully predicted clinical cancer outcomes in a pilot study.
  • This method offers potential for identifying models predictive of cancer survival and recurrence.
  • Understanding integrated biological knowledge interactions can lead to improved screening strategies and therapeutic targets for various cancers.